FindMyKOL
Clinical trialNCT02250703CompletedPhase 3Interventional

Intranasal Dexmedetomidine Premedication in Children

NCT02250703 is a phase 3 interventional trial sponsored by University of Mississippi Medical Center. As of 18 Nov 2026, it is completed. It studies Dexmedetomidine and Midazolam in Preoperative Sedation. The registry lists an enrollment of 75 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2014 and a primary completion date of 30 Sept 2016.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02250703
FieldValue
Registry IDNCT02250703
StatusCompleted
PhasePhase 3
Study typeInterventional trial
Lead sponsorUniversity of Mississippi Medical Center
Enrollment75
Registered sites1
Countries1
ConditionsPreoperative Sedation
DrugsDexmedetomidine and Midazolam
Start30 Sept 2014
Primary completion30 Sept 2016
Study completion30 Sept 2016
Last update posted7 Jul 2017

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

BACKGROUND INFORMATION AND RATIONALE Pediatric patients scheduled for dental procedures under general anesthesia can have significant anxiety before the procedure. They are commonly pre medicated to minimize distress and to facilitate a smooth induction of anesthesia. Oral Midazolam at 0.5mg/kg dose is more widely used for this purpose . However the commonly used maximum dose is up to 15mg. It also has many limitations such as paradoxical reaction, increased incidence of emergence delirium and negative postoperative behavior changes . Intranasal dexmedetomidine has been used an effective and safe alternative premedication to oral midazolam in children. At a dose of 2micrograms/kg, intranasal dexmedetomidine as premedication resulted in excellent sedation in children aged 5-8yrs with no adverse hemodynamic effects. It has other advantages such as providing analgesia and facilitating smooth emergence from anesthesia. The goal of this study is to find out if intranasal dexmedetomidine is a superior alternative as premedication to oral midazolam in children weighing more than 20kg undergoing general anesthesia for dental rehabilitation.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Madhankumar Sathyamoorthy, MBBS, MS

    University of Mississippi Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Mississippi, United States1 site
  • Children's of Mississippi/university of Mississipi Medical Center

    Jackson

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippi: 1 siteMS1AlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT02250703

Each answer restates registry values shown on this page.

What is NCT02250703?

NCT02250703 is a phase 3 interventional trial sponsored by University of Mississippi Medical Center. It studies Dexmedetomidine and Midazolam in Preoperative Sedation.

Who leads NCT02250703?

The registry names Madhankumar Sathyamoorthy, MBBS, MS (principal investigator, University of Mississippi Medical Center) as the overall official.

Where does NCT02250703 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT02250703 study?

The registered drug and biological interventions are Dexmedetomidine and Midazolam.

When did NCT02250703 end?

The registry lists a primary completion date of 30 Sept 2016 and a study completion date of 30 Sept 2016. The sponsor last updated the record on 7 Jul 2017.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.